Company: TVRD
Filing Date: 2025-01-27
Form Type: S-4/A
Source: 0001104659-25-006050
Chunk: 871

Company: Tvardi Therapeutics, Inc.
Filing Date: 2025-01-27
Form: S-4/A
Chunk 871
---
able Convertible 
        Preferred Stock 
                 Shares | ​ 
 ​ | ​      
 ​      
 Amount |      ​ 
      ​ | ​ 
 ​ 
 ​ 
 ​ 
 ​ | ​ 
 ​ 
 ​ | ​ 
 ​ 
 ​ 
 ​ |            ​ 
            ​ 
            ​ 
 Common Stock 
       Shares | ​ 
 ​ 
 ​ | ​      
 ​      
 ​      
 Amount |  ​ 
  ​ 
  ​ | ​ 
 ​ 
 ​ 
 ​ | ​          
 ​          
 Additional 
 Paid-In    
 Capital    |     ​ 
     ​ | ​ 
 ​ 
 ​ 
 ​ | ​           
 ​           
 ​           
 Accumulated 
 Deficit     |       ​ 
       ​ 
       ​ | ​ 
 ​ 
 ​ 
 ​ | ​             
 Accumulated   
 Other         
 Comprehensive 
 Loss          | ​ | ​ 
 ​ 
 ​ 
 ​ | ​             
 ​             
 Total         
 Stockholders’ 
 Deficit       |       ​ 
       ​ |
|:----------------------------------|:--|-----------------------:|:--|:-------|-------:|:--|:--|:--|-------------:|:--|:-------|---:|:--|:-----------|------:|:--|:------------|--------:|:--|:--------------|:--|:--|:--------------|--------:|
| Balances as of January 1, 2024    |   |             29,555,538 | ​ | $      | 85,503 | ​ | ​ |   |   19,134,164 | ​ | $      | 19 | ​ | $          |   762 | ​ | $           | -62,839 | ​ | $             | — | ​ | $             | -62,058 |
| Exercise of stock options         |   |                      — | ​ |        |      — | ​ | ​ |   |       63,750 | ​ |        |  — | ​ |            |     5 | ​ |             |       — | ​ |               | — | ​ |               |       5 |
| Stock-based compensation          |   |                      — | ​ |        |      — | ​ | ​ |   |            — | ​ |        |  — | ​ |            |   240 | ​ |             |       — | ​ |               | — | ​ |               |     240 |
| Net loss                          |   |                      — | ​ |        |      — |